Clinical Trial: Study of Isavuconazole Prophylaxis in Adults With Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) and Neutropenia

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Phase II Study of Isavuconazole Prophylaxis in Adult Patients With Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) and Neutropenia

Brief Summary:

AML/MDS and their treatment may weaken participant's immune system and may make participant more likely to develop invasive fungal infections (IFIs).

The goal of this clinical research study is to learn if isavuconazole can help prevent invasive aspergillosis (IA) and other IFIs in patients with AML/MDS. The safety of this drug will also be studied.